Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling

相似書籍

• PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL
  由: El-Gamal, Dalia, et al.
  出版: (2014)
• Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
  由: Liu, Ta-Ming, et al.
  出版: (2015)
• Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL
  由: Chen, Shih-Shih, et al.
  出版: (2011)
• Constitutive activation of Lyn kinase enhances BCR responsiveness, but not the development of CLL in Eµ-TCL1 mice
  由: Kohlhas, Viktoria, et al.
  出版: (2020)
• Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL
  由: Herman, Sarah E. M., et al.
  出版: (2014)